Mintz advised QIAGEN on the deal. QIAGEN N.V. announced its $150 million completed acquisition of Verogen, a leader in the use of next-generation sequencing technologies to drive...
QIAGEN’s $150 Million Acquisition Of Verogen
Cardurion Pharmaceuticals’ $300 Million Investment
Mintz advised Cardurion Pharmaceuticals on the deal. Cardurion Pharmaceuticals, Inc. (Cardurion), a clinical-stage biotechnology company, announced a private investment of up to $300 million from Bain Capital...